Published in Physics World, 21 Aug 2013
A neutron study of a common component of HIV drugs has revealed that the component is not as good at bonding as had been thought. The study, performed by an international group of researchers, highlights aspects of the drug component that could be improved to make it better at mitigating the effects of HIV.
HIV is a virus that replicates through use of a person’s immune system. HIV implants genetic information into the immune system’s T-cells, which then produce copies of the virus until they die. Once enough T-cells have died from churning out HIV, the person is unable to ward off other infections and they are said to be suffering from AIDS. […]
The rest of this article is available here.